An interdisciplinary effort by mathematical modelers, clinicians and virologists has revealed that daclatasvir has two main modes of action against HCV and also yields a more accurate new estimate of the HCV half-life.
Fuente : http://www.eurekalert.org/pub_releases/2013-02/luh…
Hacer un comentario